Pfizer Acquires Seagen Inc – Pfizer Invests $43bn to Battle Cancer
in Company Report , Healthcare & Life Sciences , Healthcare & Life Sciences , Industry Report , Pharma & Biotech on March 20, 2023Pfizer Acquires Seagen
have announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a pioneer in antibody drug conjugate technology is called ADC, which is rapidly emerging as a powerful tool in cancer treatment.
Executive Summary
Deal Overview
Company Overview – Seagen
Company Overview – Pfizer
No of Pages: 79
To view another Acquisition report click here
Follow our LinkedIn page for more updates
Recent Blog Posts
Related Products
Popular & Trending
Featured Products
